Penile Traction Device for Peyronie's Disease

Peyronie's disease is unsettling to live with, and most men researching it want the same thing: a way to address the curvature that does not start with surgery. Penile traction therapy (PTT) is one of the most studied conservative answers to that question, and this page explains how a traction device fits into Peyronie's care — soberly, without overpromising. It covers how traction addresses curvature, what peer-reviewed studies actually report, the device features that matter when tissue is involved, and the safety boundaries that make this a medical decision rather than a casual purchase.

That is the honest summary, and the rest of this page unpacks it. The scope here is deliberately narrow: this is the device-and-application angle — how a traction device is used for Peyronie's disease — not a survey of every treatment available. Peyronie's care also includes oral medication, injectable therapy, and, in selected cases, surgery; the full picture is set out in the guide to Peyronie's disease treatment options. Traction belongs to the conservative end of that spectrum — non-surgical, gradual, and best understood as one tool a urologist may recommend, sometimes on its own and sometimes alongside other treatments. What follows explains how it works on curvature, what the evidence supports, and where the medical guardrails are.

Peyronie's disease is the formation of fibrous scar tissue — called plaque — within the tunica albuginea, the tough elastic sheath that surrounds the erectile chambers of the penis. Because the plaque is less flexible than the healthy tissue around it, the penis bends toward the scar during an erection. The result is penile curvature, sometimes accompanied by pain and sometimes by a degree of penile shortening. Peyronie's disease typically moves through two phases.

• Acute (active) phase. The plaque is still forming, the curvature can change from month to month, and erections are more likely to be painful. This phase is unsettled and is the one that most needs medical oversight.
• Chronic (stable) phase. The plaque has matured, the curvature has settled, and pain has usually eased. This is the more predictable phase, and the more common window for self-directed conservative treatment.

This is a deliberately brief sketch — diagnosis and staging belong to a urologist, who can confirm whether curvature is caused by Peyronie's disease and which phase it is in. For how traction sits among the other options, see Peyronie's disease treatment options.

Penile traction therapy addresses curvature by working with the tissue's own repair biology rather than against it. The mechanism is called mechanotransduction: when living tissue is held under sustained, gentle, calibrated tension, its cells sense that mechanical signal and respond by gradually remodelling the surrounding structure. Applied to Peyronie's disease, that sustained force encourages the fibrous plaque and the tunica albuginea around it to slowly elongate and realign, so that the difference in flexibility between scarred and healthy tissue is reduced over time.

It is worth being precise about what this does and does not mean. Traction does not dissolve plaque, and it does not deliver a sudden correction. It promotes gradual tissue remodelling — plaque elongation and a partial realignment — and the change accumulates slowly across months of consistent wear. The underlying physical process is the same one described for general lengthening in how a penile traction device works, but the goal here is different. On a general lengthening page the aim is added length; in Peyronie's disease the priority is curvature reduction and preserving or recovering the length the condition has taken away.

Because the effect is biological and gradual, the dose that matters is time: hours of calibrated traction per day, sustained over months. That is also why honest framing matters — traction can help reduce curvature, but it works partially and slowly, and it is one input into a process the body itself carries out.

Peer-reviewed studies of penile traction therapy in Peyronie's disease point in a consistent direction: traction can produce modest but measurable improvement. The evidence is best read soberly, as a body of work that supports traction as a reasonable conservative option — not as a promise of a specific result. Three findings recur across the published research.

• Measurable curvature reduction. Studies report that consistent traction is associated with a reduction in penile curvature for many men. An early prospective study by Gontero and colleagues (2009), in the Journal of Sexual Medicine, examined a penile extender used specifically for Peyronie's curvature and reported a measurable lessening of the bend; the 2023 systematic review and meta-analysis by Almsaoud and colleagues, published in Translational Andrology and Urology, pooled the subsequent evidence and likewise reported curvature improvement across the studies it examined. The improvement is partial — evidence suggests a meaningful reduction of the bend rather than a fully straight result.
• Recovery of some lost length. Research also suggests that traction can help recover a portion of the penile length that Peyronie's disease takes away. The single-centre pilot study of penile traction therapy in Peyronie's disease by Levine, Newell and Taylor (2008), in the Journal of Sexual Medicine, reported recovered length alongside reduced curvature, and the Almsaoud meta-analysis reported pooled length gains across its included studies. Throughout the evidence this is framed as a gradual, partial gain, not a guaranteed figure.
• Adherence drives outcome. The studies consistently report that results track daily wear time and treatment duration — higher hours per day and longer overall treatment are associated with better outcomes than short or inconsistent use. Both the Almsaoud meta-analysis and the controlled multicentre study of stable-phase traction by Moncada and colleagues (2019), published in BJU International, identify consistent adherence as the dominant predictor of how much a man improves.

The honest takeaway is that the clinical evidence validates penile traction therapy as a legitimate conservative treatment worth discussing with a urologist — while being equally clear that it is not a cure and that individual results genuinely vary.

Not every traction device is suited to a months-long Peyronie's protocol. When tissue is scarred and sometimes sensitive, five device features matter more than marketing claims.

1. Calibrated, measurable traction. The device should apply force within a defined therapeutic window — roughly 900–1,500 gram-force (9–15 N, 2–3.3 lbf) — so the dose is known and repeatable rather than guesswork. Calibrated force is what the clinical evidence is built on.
2. A comfort system for long daily wear. Peyronie's protocols call for many hours of wear each day, and comfort is what makes that achievable — a well-padded comfort strap and a secure base ring are what keep long wear bearable, and a device that lacks them simply is not worn long enough to work. Fit and comfort are covered in penile traction device comfort and pain.
3. Fine adjustability. Small, incremental tension steps — set through the device's calibrated elongation bars — matter when tissue is sensitive, so the device can be progressed gradually rather than in large, uncomfortable jumps.
4. A genuine medical-device standard. A traction device used for a medical condition should be a regulated instrument, not an improvised tool. SizeGenetics, for example, is an FDA-registered Class II medical device — a manufacturing and device-listing standard, which is not the same as FDA approval.
5. Durability over months. Peyronie's treatment runs for months, so the device must hold calibration and stay reliable for the full course. The criteria for choosing one are set out in the best penile traction device guide and the penile traction device buy guide.

How a traction device is used depends heavily on which phase of Peyronie's disease a man is in. The acute and chronic phases are not interchangeable, and treating them the same way is a common mistake.

Acute (active) phase — supervised use only

1. Start with a medical evaluation. In the acute phase the plaque is still forming, the curvature can change, and erections may be painful. Consult your healthcare provider before any traction is used — self-directed traction is not appropriate here.
2. Follow a urologist's protocol. If traction is recommended during the active phase, it should be done under a urologist's guidance, usually starting with gentle force and shorter wear, and adjusted based on how the tissue responds.
3. Stop and report pain. Increasing pain, numbness, or new symptoms during the acute phase mean stopping and returning to the doctor — not pushing through.

Chronic (stable) phase — the usual self-directed window

1. Confirm the phase first. Self-directed traction is generally for the stable phase, once a urologist has confirmed the curvature has settled.
2. Build wear time gradually. Begin within the calibrated window and increase daily hours step by step, allowing the tissue to adapt.
3. Reposition and check comfort. Reposition the device through the day, check for pinching or numbness, and treat comfort as part of the protocol, not an afterthought.

The general step-by-step routine — measuring, fitting, and progressing tension — is the same as for any traction user and is detailed in how to use a penile traction device, while the mechanism the routine relies on is explained in how a penile traction device works. Whichever phase applies, consult your healthcare provider before starting.

Realistic expectations are part of using traction well. Improvement in Peyronie's disease is measured over months, not weeks, and it is partial — the goal is a meaningful reduction in curvature, not necessarily a perfectly straight penis. Consistency is the strongest predictor of how much a man improves.

The multi-month course this timeline describes is consistent with the treatment durations in the peer-reviewed studies summarised above — including the Almsaoud and colleagues (2023) meta-analysis and the Moncada and colleagues (2019) stable-phase study — where longer, sustained use tracks with better reported outcomes. Some men use traction alongside other Peyronie's treatments under medical guidance, and that combined approach is a decision for a urologist. There are no guarantees here — the documented timelines and outcome ranges are discussed in penis extender results: before and after, which should be read as typical reported experience rather than a promise.

Peyronie's disease is a medical condition, and traction is a medical decision. Some situations call for a urologist before anything else — see one promptly if any of the following apply.

• New or worsening curvature. A bend that has appeared recently or is still changing should be evaluated before any self-treatment.
• Painful erections. Ongoing pain with erections is a sign the condition may be in the active phase and needs medical assessment.
• Significant deformity affecting function. Curvature severe enough to interfere with sexual function or urination warrants a specialist's input.
• Sudden onset. Symptoms that appeared suddenly should be checked rather than managed at home.

Do not self-treat the acute phase without medical input. Once traction is under way, stop and seek care for persistent pain, numbness, skin changes, or any new symptom; the difference between a fixable fit problem and a symptom that warrants stopping is set out in penile traction device comfort and pain. None of the information on this page replaces a clinical assessment — consult your healthcare provider before starting traction, and again if anything changes. Used within these boundaries, traction is a considered part of Peyronie's care; used carelessly, it is a risk.

To go deeper, move from this page into the rest of the cluster — starting with the hub, penile traction device: how medical devices deliver therapy, and the full product detail on the SizeGenetics medical traction device page.